Goals

Overarching Goals

  • To enable the development of new and effective treatments and medicines through innovative products.
  • Continue to establish Genovis products as valuable tools throughout the customer’s value chain from discovery to production of pharmaceuticals.
  • Genovis will create long-term shareholder value through results that generate both dividends for shareholders and funding for innovation and growth initiatives for the continued development of the Company.

Targets 2026-2028

Financial Targets

  • EBITDA margin of at least 30% by the end of the 2026–2028 period.
  • Sales growth of 20% per year over a three-year period.

Operational Objectives

  • At least three product launches annually.
  • Svenska